Wall Street is taking President Donald Trump’s latest threat on tariffs in stride, on the whole, and U.S. stocks are drifting higher on Monday.

Amid the growing discussion about China's economic resilience in light of US President Donald Trump's tariff policies, recent ...

The Oracle of Omaha scooped up shares of three stocks -- including two legal monopolies -- and dumped close to $1.3 billion ...

The first tariff salvo came in January after Colombian President Gustavo Petro revoked landing rights to a U.S. military flight carrying deportees. Trump announced he was levying 25% tariffs against ...

KeyBanc Capital Markets analyst Matthew Gillmor increased the price target on Encompass Health Corp (NYSE:EHC) to $120 from $117, while maintaining an Overweight rating on the company's shares. The ...

The well-known hedge fund manager has announced a massive holding in this tech stock for his FTSE 100-listed investment trust.

Who owns the biggest companies in the country? Millions of shareholders. However, a handful of giant institutional investors ...

With BTC ETF buying leading the charge, profits cannot easily flow into products without listings on the NYSE or Nasdaq.

Boeing reported a massive quarterly (and even more massive full-year) loss last month. Charges incurred to deal with the IAM ...

Trump’s latest move isn’t merely another trade skirmish; it’s an escalation of his “America First” trade doctrine where “no ...

Although much of this decline came last week, the inventory de-stocking issue has weighed on the company’s performance lately ...

Drugmaker Incyte Corp reported fourth-quarter revenue above Wall Street estimates on Monday, boosted by strong demand for its key blood-cancer drug Jakafi and skin-disorder treatment Opzelura.